Valuation : Abbott Laboratories

Market Cap 197B 169B 159B 145B 274B 18,831B 275B 1,882B 729B 9,500B 741B 725B 31,466B P/E 2026 *
32.7x
P/E 2027 * 25.2x
Enterprise Value 221B 190B 178B 163B 307B 21,114B 309B 2,111B 818B 10,652B 831B 813B 35,281B EV / Sales 2026 *
4.4x
EV / Sales 2027 * 4x
Free-Float
86.16%
Yield 2026 *
2.25%
Yield 2027 * 2.4%
1 day-1.75%
1 week-0.29%
Current month+7.95%
1 month+10.71%
3 months+31.65%
6 months-1.86%
Current year-8.93%
1 week 113.45
Extreme 113.4501
117.34
1 month 102.89
Extreme 102.89
117.34
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap.
8/12/26 Other

EXECUTIVE VICE PRESIDENT

-12 0.0000%
6/30/26 Free

Director

416 0.0000%
6/30/26 Free

Director

432 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.75%-0.29%-13.29%+9.49% 197B
+0.97%-2.24%-0.17%+11.96% 118B
-0.08%+3.37%+13.15%+82.63% 62.55B
-2.00%-3.74%+27.02%+53.48% 52.4B
+0.23%+1.39%-1.99%-32.07% 51.81B
-0.22%-1.02%+16.87%-11.71% 33.57B
-2.97%+1.98% - - 30.34B
+0.41%-0.81%+43.12%-11.13% 24.63B
-0.47%+3.56%-3.25%+19.21% 23.81B
+0.14%-0.06%-4.75%+4.58% 23.09B
Average -0.57%+0.78%+8.52%+14.05% 61.74B
Weighted average by Cap. -0.69%+0.07%+1.59%+16.16%

Financials

2026 *2027 *
Net sales 50.3B 43.17B 40.52B 37.01B 69.85B 4,798B 70.19B 480B 186B 2,420B 189B 185B 8,017B 54.65B 46.9B 44.02B 40.21B 75.88B 5,212B 76.25B 521B 202B 2,629B 205B 201B 8,709B
Net income 6.23B 5.35B 5.02B 4.59B 8.65B 594B 8.7B 59.42B 23.03B 300B 23.4B 22.89B 993B 7.92B 6.8B 6.38B 5.83B 11B 756B 11.06B 75.55B 29.28B 381B 29.75B 29.11B 1,263B
Net Debt 23.94B 20.55B 19.29B 17.61B 33.24B 2,283B 33.4B 228B 88.45B 1,152B 89.88B 87.93B 3,815B 20.96B 17.99B 16.88B 15.42B 29.1B 1,999B 29.24B 200B 77.43B 1,008B 78.69B 76.98B 3,340B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change
26-08-26 $114.10 -1.75%
26-08-25 $116.13 -0.46%
26-08-24 $116.67 +0.03%
26-08-21 $116.64 +2.19%
26-08-20 $114.14 -0.25%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
114.10USD
Average target price
120.20USD
Spread / Average Target
+5.35%

Quarterly revenue - Rate of surprise